Beijing Tiantan Biological Products Co., Ltd. (SHA:600161)

SHA:600161 Revenue

Beijing Tiantan Biological Products had revenue of 1.23B CNY in the quarter ending September 30, 2024, a decrease of -7.44%. This brings the company's revenue in the last twelve months to 5.23B, down -2.59% year-over-year. In the year 2023, Beijing Tiantan Biological Products had annual revenue of 5.18B with 21.57% growth.

• Revenue (ttm): 5.23B
• Revenue Growth: -2.59%
• P/S Ratio: 7.65
• Revenue / Employee: 1.08M
• Employees: 4,858
• Market Cap: 39.65B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	5.18B	919.14M	21.57%
Dec 31, 2022	4.26B	149.15M	3.63%
Dec 31, 2021	4.11B	666.56M	19.35%
Dec 31, 2020	3.45B	163.74M	4.99%
Dec 31, 2019	3.28B	350.80M	11.97%